Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Edwards

Showing results (11-20 of 196) with videos related to

Pageof 20
Sort By:
Expert Opinion on Drug Discovery|July 28, 2020
Explaining biosimilars and how reverse engineering plays a critical role in their developmentSalvatore Bellinvia, Christopher J Edwards
Seminars in Arthritis and Rheumatism|July 2, 2003
Intravenous pulses of methylprednisolone for systemic lupus erythematosusHumeira Badsha, Christopher J Edwards
Expert Review of Clinical Immunology|November 6, 2018
Upadacitinib for the treatment of rheumatoid arthritisLina Serhal, Christopher J Edwards
Lupus|October 9, 2024
JAK inhibitors in systemic lupus erythematosus: Translating pathogenesis into therapyGabriela Ceobanu, Christopher J Edwards
Rheumatology (Oxford, England)|April 12, 2026
Novel glucocorticoids: current status and challengesFrank Buttgereit, Christopher J Edwards
American Journal of Respiratory and Critical Care Medicine|January 4, 2007
Study of infliximab treatment in asthmaChristopher J Edwards, Riccardo Polosa
Lupus|March 20, 2020
BiosimilarsChristopher J Edwards, Salvatore Bellinvia
Arthritis Research|May 16, 2002
Statins as modulators of bone formationChristopher J Edwards, Tim D Spector
Therapeutic Advances in Musculoskeletal Disease|August 2, 2012
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidityJonathan L Marks, Christopher J Edwards
The Annals of Pharmacotherapy|April 24, 2025
Overview of Challenges With Using Cost-Effectiveness Analysis for Evaluating MedicationsChristopher J Edwards, Brian L Erstad
Pageof 20

Showing results (11-20 of 196) with videos related to

Sort By:
Pageof 20
Expert Opinion on Drug Discovery|July 28, 2020
Explaining biosimilars and how reverse engineering plays a critical role in their developmentSalvatore Bellinvia, Christopher J Edwards
Seminars in Arthritis and Rheumatism|July 2, 2003
Intravenous pulses of methylprednisolone for systemic lupus erythematosusHumeira Badsha, Christopher J Edwards
Expert Review of Clinical Immunology|November 6, 2018
Upadacitinib for the treatment of rheumatoid arthritisLina Serhal, Christopher J Edwards
Lupus|October 9, 2024
JAK inhibitors in systemic lupus erythematosus: Translating pathogenesis into therapyGabriela Ceobanu, Christopher J Edwards
Rheumatology (Oxford, England)|April 12, 2026
Novel glucocorticoids: current status and challengesFrank Buttgereit, Christopher J Edwards
American Journal of Respiratory and Critical Care Medicine|January 4, 2007
Study of infliximab treatment in asthmaChristopher J Edwards, Riccardo Polosa
Lupus|March 20, 2020
BiosimilarsChristopher J Edwards, Salvatore Bellinvia
Arthritis Research|May 16, 2002
Statins as modulators of bone formationChristopher J Edwards, Tim D Spector
Therapeutic Advances in Musculoskeletal Disease|August 2, 2012
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidityJonathan L Marks, Christopher J Edwards
The Annals of Pharmacotherapy|April 24, 2025
Overview of Challenges With Using Cost-Effectiveness Analysis for Evaluating MedicationsChristopher J Edwards, Brian L Erstad
Pageof 20